⌘K
t
CVS Group plc announced an interim review of its block listing arrangements for three sharesave schemes, covering the period from 12 July 2022 to 11 January 2023. During this period, 118,882 ordinary shares were allotted across these schemes. Additionally, on 10 January 2023, the company issued 106,955 and 1,474 new Ordinary Shares related to other employee share options, resulting in a total issued share capital and voting rights of 71,380,400 Ordinary Shares.
| Date | 11 Jan 2023 |
| Time | 16:31:00 |
| Category | Capital structure |
| ID | 4416M |
11 January 2023
CVS Group plc
("CVS" or the "Company")
Block Listing Interim Review and TVR Update
CVS, one of the UK's leading providers of integrated veterinary services, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements. References to securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").
|
Name of the company: |
CVS Group plc
|
|||
|
Name of relevant scheme: |
1. CVS Group plc 2017-2020 Sharesave Scheme; 2. CVS Group plc 2018-2021 SAYE Sharesave Scheme; and 3. CVS Group 2018 SAYE Plan
|
|||
|
Period of return: |
From: |
12 July 2022 |
To: |
11 January 2023 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1. 230 2. 19,598 3. 348,290 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil 3. Nil |
|||
|
Less: Number of securities issued / allotted under scheme(s) during period: |
1. 0 2. 6,734 3. 112,148 |
|||
|
Equals: Balance under scheme(s) not yet issued / allotted at end of period: |
1. 230 2. 12,864 3. 236,142 |
|||
|
Number and class of securities originally listed and the date of admission: |
1. 114,302 Ordinary Shares admitted on 11 January 2021 and 1,535 Ordinary Shares admitted on 1 September 2021 2. 296,069 Ordinary Shares admitted on 1 September 2021 3. 350,000 Ordinary Shares admitted on 30 December 2021 |
|||
Total Voting Rights
The number of securities that have been issued during the block listing review period stated above includes 106,955 new Ordinary Shares issued on 10 January 2023 in connection with the exercise of employee share options under the CVS Group plc 2019-2023 SAYE Sharesave Scheme and a further 1,474 new Ordinary Shares issued on 10 January 2023 in connection with the exercise of employee options under the CVS Group plc 2018-2022 SAYE Sharesave Scheme.
Following the issue of these new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, the Company has a total issued share capital of 71,380,400 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury so the total number of voting rights is therefore 71,380,400.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Toby Strong +44 (0)7789 151 644